Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt
- Authors
- Jia, Yaoyao; Wu, Chunyan; Kim, Jiyoung; Kim, Bobae; Lee, Sung-Joon
- Issue Date
- 2월-2016
- Publisher
- ELSEVIER SCIENCE INC
- Keywords
- Astaxanthin; PPAR; Akt; SREBP1; Autophagy
- Citation
- JOURNAL OF NUTRITIONAL BIOCHEMISTRY, v.28, pp.9 - 18
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Volume
- 28
- Start Page
- 9
- End Page
- 18
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/89625
- DOI
- 10.1016/j.jnutbio.2015.09.015
- ISSN
- 0955-2863
- Abstract
- We have previously reported that astaxanthin (AX), a dietary carotenoid, directly interacts with peroxisome proliferator-activated receptors PPAR alpha and PPAR gamma, activating PPAR alpha while inhibiting PPAR gamma, and thus reduces lipid accumulation in hepatocytes in vitro. To investigate the effects of AX in vivo, high-fat diet (HFD)-fed C57BL/6J mice were orally administered AX (6 or 30 mg/kg body weight) or vehicle for 8 weeks. AX significantly reduced the levels of triglyceride both in plasma and in liver compared with the control HFD mice. AX significantly improved liver histology and thus reduced both steatosis and inflammation scores of livers with hematoxylin and eosin staining. The number of inflammatory macrophages and Kupffer cells were reduced in livers by AX administration assessed with F4/80 staining. Hepatic PPAR alpha-responsive genes involved in fatty acid uptake and beta-oxidation were upregulated, whereas inflammatory genes were downregulated by AX administration. In vitro radiolabeled assays revealed that hepatic fatty acid oxidation was induced by AX administration, whereas fatty acid synthesis was not changed in hepatocytes. In mechanism studies, AX inhibited Akt activity and thus decreased SREBP1 phosphorylation and induced Insig-2a expression, both of which delayed nuclear translocation of SREBP1 and subsequent hepatic lipogenesis. Additionally, inhibition of the Akt-mTORC1 signaling axis by AX stimulated hepatic autophagy that could promote degradation of lipid droplets. These suggest that AX lowers hepatic lipid accumulation in HFD-fed mice via multiple mechanisms. In addition to the previously reported differential regulation of PPAR alpha and PPAR gamma, inhibition of Akt activity and activation of hepatic autophagy reduced hepatic steatosis in mouse livers. (C) 2015 Elsevier Inc. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biotechnology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.